Search results
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 3 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 3 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Digital Journal· 3 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
New study helps explain how elderly individuals react differently to COVID-19 than young people
Medical Xpress· 3 days agoThe COVID-19 pandemic resulted in over 700 million infections and 7 million deaths worldwide. While age is recognized as a risk factor for severe COVID-19, the reasons for this are not yet fully understood.
Paxlovid Doesn't Cure Long COVID
Time via Yahoo News· 6 days agoThe rest of the group took a placebo with ritonavir, which doesn't work against the SARS-CoV-2 virus on its own. Ritonavir enhanced the ...
Bayesian Capital Management LP Invests $4.79 Million in Hologic, Inc. (NASDAQ:HOLX)
ETF DAILY NEWS· 12 hours agoBayesian Capital Management LP purchased a new position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) in the 4th quarter, according to the company in its most recent filing with the ...
Household study suggests infants may spread C difficile
Center for Infectious Disease Research and Policy· 3 days agoA longitudinal household study found shared C difficile strains in 17 of 28 families, with the...
GT Molecular Announces an Ultra-Sensitive RT-PCR Multiplex Panel for Eight Key KRAS G12-G13...
FOX 59 Indianapolis· 3 hours agoGT Molecular, Inc., a leader in developing ultra-sensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology testing, is adding to its cancer molecular assay ...
Paxlovid fails to improve long COVID symptoms in small study
Center for Infectious Disease Research and Policy· 6 days agoThe mean time between index SARS-CoV-2 infection and randomization was 17.5 months. At 10 weeks...
COVID-19 Death Determination Methods, Minnesota, USA, 2020–2022
Centers for Disease Control and Prevention· 7 days agoIn addition, access to provisional death certificates is a consistently expeditious method for obtaining reports of potential COVID-19–associated deaths. In our analysis, median days between ...